Dr. Alice Gottlieb
Dr. Alice B. Gottlieb, an internationally recognized expert in psoriasis, psoriatic arthritis, and related disorders, received her MD from Cornell Medical School and her PhD from the Rockefeller University, where she studied in the laboratory of Henry Kunkel and was one of the first women admitted to Rockefeller University/Cornell University School of Medicine’s joint MD-PhD program. Her translational research provided the first double-blind, randomized, placebo-controlled study of TNF blockers as monotherapy for moderate to severe psoriasis (published in The Lancet in 2001), which led to multiple TNF blockers being FDA-approved for psoriasis. She has authored over 350 peer-reviewed articles that have appeared in journals such as The Lancet, the New England Journal of Medicine, and Nature: Drug Discovery. She is Professor of Dermatology at New York Medical College’s Metropolitan Hospital Campus in New York City. She is triple boarded in dermatology, rheumatology, and internal medicine.